DK1102776T3 - Vandoplöselige prodrugs af hindrede phenoler - Google Patents

Vandoplöselige prodrugs af hindrede phenoler

Info

Publication number
DK1102776T3
DK1102776T3 DK99939030T DK99939030T DK1102776T3 DK 1102776 T3 DK1102776 T3 DK 1102776T3 DK 99939030 T DK99939030 T DK 99939030T DK 99939030 T DK99939030 T DK 99939030T DK 1102776 T3 DK1102776 T3 DK 1102776T3
Authority
DK
Denmark
Prior art keywords
water
hindered phenols
soluble prodrugs
prodrugs
soluble
Prior art date
Application number
DK99939030T
Other languages
Danish (da)
English (en)
Inventor
Valentino J Stella
Jan J Zygmunt
Ingrid Gunda Georg
Muhammed S Safadi
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Application granted granted Critical
Publication of DK1102776T3 publication Critical patent/DK1102776T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK99939030T 1998-08-07 1999-08-06 Vandoplöselige prodrugs af hindrede phenoler DK1102776T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/131,385 US6204257B1 (en) 1998-08-07 1998-08-07 Water soluble prodrugs of hindered alcohols

Publications (1)

Publication Number Publication Date
DK1102776T3 true DK1102776T3 (da) 2006-07-10

Family

ID=22449234

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99939030T DK1102776T3 (da) 1998-08-07 1999-08-06 Vandoplöselige prodrugs af hindrede phenoler

Country Status (27)

Country Link
US (4) US6204257B1 (zh)
EP (2) EP1102776B1 (zh)
JP (1) JP4554081B2 (zh)
KR (1) KR100662799B1 (zh)
CN (2) CN1198834C (zh)
AT (1) ATE319723T1 (zh)
AU (1) AU769755B2 (zh)
BR (1) BR9912853A (zh)
CA (1) CA2339834C (zh)
CY (1) CY1105043T1 (zh)
CZ (1) CZ304020B6 (zh)
DE (1) DE69930269T2 (zh)
DK (1) DK1102776T3 (zh)
ES (1) ES2268876T3 (zh)
HK (1) HK1047939B (zh)
HU (1) HU229401B1 (zh)
IL (1) IL141316A (zh)
MX (1) MXPA01001431A (zh)
NO (1) NO330357B1 (zh)
NZ (1) NZ509795A (zh)
PL (1) PL198141B1 (zh)
PT (1) PT1102776E (zh)
RU (1) RU2235727C2 (zh)
TR (1) TR200100772T2 (zh)
UA (1) UA73479C2 (zh)
WO (1) WO2000008033A1 (zh)
ZA (1) ZA200101039B (zh)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
ATE252889T1 (de) * 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6362234B1 (en) * 2000-08-15 2002-03-26 Vyrex Corporation Water-soluble prodrugs of propofol for treatment of migrane
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
CN1507451A (zh) * 2001-04-20 2004-06-23 �±Ȱ·�ķ�ɷ����޹�˾ 可用作前体药物的修饰环孢菌素及其应用
WO2003026632A2 (en) * 2001-09-26 2003-04-03 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
JP4369237B2 (ja) * 2001-12-21 2009-11-18 エーザイ コーポレーション オブ ノース アメリカ アルコールおよびフェノールの水溶性ホスホノオキシメチル誘導体の調製法
CA2470500C (en) * 2001-12-28 2012-05-15 Guilford Pharmaceuticals, Inc. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
PL373850A1 (en) * 2002-04-08 2005-09-19 Guilford Pharmaceuticals, Inc. Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
ITRM20020306A1 (it) 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
ZA200504940B (en) * 2003-01-28 2006-09-27 Xenoport Inc Amino acid derived prodrugs of propofol, compositions and uses thereof
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US7230003B2 (en) * 2003-09-09 2007-06-12 Xenoport, Inc. Aromatic prodrugs of propofol, compositions and uses thereof
AU2004286814A1 (en) * 2003-10-24 2005-05-19 Auspex Pharmaceuticals, Inc. pH sensitive prodrugs of 2,6-diisopropylphenol
US7834043B2 (en) * 2003-12-11 2010-11-16 Abbott Laboratories HIV protease inhibiting compounds
KR20060124619A (ko) * 2003-12-17 2006-12-05 엠쥐아이 쥐피, 아이엔씨. 연장된 진정을 위해 프로포폴의 수용성 프로드럭을투여하는 방법
EP1745064B1 (en) 2004-04-15 2011-01-05 Proteolix, Inc. Compounds for proteasome enzyme inhibition
US7232818B2 (en) * 2004-04-15 2007-06-19 Proteolix, Inc. Compounds for enzyme inhibition
US8198270B2 (en) * 2004-04-15 2012-06-12 Onyx Therapeutics, Inc. Compounds for proteasome enzyme inhibition
PL2030981T3 (pl) 2004-05-10 2014-12-31 Onyx Therapeutics Inc Związki do enzymatycznej inhibicji proteasomu
US20050256324A1 (en) * 2004-05-10 2005-11-17 Proteolix, Inc. Synthesis of amino acid keto-epoxides
CN101023090B (zh) 2004-07-06 2013-03-27 雅培制药有限公司 Hiv蛋白酶抑制剂的前药
WO2006017351A1 (en) * 2004-07-12 2006-02-16 Xenoport, Inc. Prodrugs of propofol, compositions and uses thereof
DE602005010270D1 (de) * 2004-07-12 2008-11-20 Xenoport Inc Von aminosäuren abgeleitete prodrugs von propofolzusammensetzungen und anwendungen davon
US20060014677A1 (en) * 2004-07-19 2006-01-19 Isotechnika International Inc. Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
WO2006027711A2 (en) * 2004-08-26 2006-03-16 Nicholas Piramal India Limited Prodrugs and codrugs containing bio- cleavable disulfide linkers
WO2006033911A2 (en) * 2004-09-17 2006-03-30 Mgi Gp, Inc. Methods of administering water-soluble prodrugs of propofol
JP2008525501A (ja) * 2004-12-23 2008-07-17 ゼノポート，インコーポレイティド セリンアミノ酸誘導のプロポフォールのプロドラッグ、その使用及び結晶体
WO2006133506A1 (en) 2005-06-17 2006-12-21 Vital Health Sciences Pty Ltd A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
AU2006268326A1 (en) * 2005-07-12 2007-01-18 Eisai Inc. Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation
WO2007022437A2 (en) * 2005-08-18 2007-02-22 Auspex Pharmaceuticals, Inc. Therapeutic agents for the treatment of cancer and metabolic disorders
ES2334045T3 (es) 2005-08-18 2010-03-04 Zimmer Gmbh Articulos de polietileno de alto peso molecular y procedimientos para formar articulos de polietileno de alto peso molecular.
US7589239B2 (en) * 2005-09-02 2009-09-15 Auspex Pharmaceuticals Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
US20090114877A1 (en) * 2005-09-13 2009-05-07 Eisai R&D Management Co., Ltd. Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same
PT2623113T (pt) 2005-11-09 2017-07-14 Onyx Therapeutics Inc Compostos para inibição de enzimas
JP5226679B2 (ja) 2006-06-19 2013-07-03 プロテオリックス， インコーポレイテッド 酵素阻害のための化合物
JP2010505826A (ja) * 2006-10-05 2010-02-25 エーザイ インコーポレイテッド プロポフォールの水溶性プロドラッグの水ベースの薬学的製剤
US20080161400A1 (en) * 2006-10-26 2008-07-03 Xenoport, Inc. Use of forms of propofol for treating diseases associated with oxidative stress
US8664290B2 (en) 2007-04-10 2014-03-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
ES2662102T3 (es) 2007-04-10 2018-04-05 Zimmer, Inc. Un polietileno reticulado de peso molecular ultra alto estabilizado con antioxidantes para aplicaciones en dispositivos médicos
CA2685813A1 (en) 2007-05-09 2008-11-20 Pharmacofore, Inc. Therapeutic compounds
NZ580752A (en) 2007-05-09 2012-03-30 Pharmacofore Inc Stereoisomers propofol therapeutic compounds
US20090005444A1 (en) * 2007-06-21 2009-01-01 Xenoport, Inc. Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus
FI20070574A0 (fi) * 2007-07-30 2007-07-30 Kuopion Yliopisto Vesiliukoinen propofolin etylideenifosfaatti-aihiolääke
US8427384B2 (en) 2007-09-13 2013-04-23 Aerosat Corporation Communication system with broadband antenna
CN104505594B (zh) * 2007-09-13 2018-07-24 天文电子学爱罗莎特股份有限公司 有宽带天线的通信系统
US20090076141A1 (en) * 2007-09-14 2009-03-19 Xenoport, Inc. Use of Propofol Prodrugs for Treating Neuropathic Pain
US20090075947A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched fospropofol
EA024437B1 (ru) * 2007-10-04 2016-09-30 Оникс Терапьютикс, Инк. Синтез кето-эпоксидов аминокислот
US20090098209A1 (en) * 2007-10-15 2009-04-16 University Of Kansas Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration
WO2009120162A1 (ru) * 2008-03-25 2009-10-01 Zhukovskij Oleg Igorevich Субстанция "ua' orion"
AU2009249067A1 (en) * 2008-05-20 2009-11-26 Neurogesx, Inc. Water-soluble acetaminophen analogs
MX2010012649A (es) 2008-05-20 2010-12-21 Neurogesx Inc Profarmacos de carbonato y metodos para usar los mismos.
WO2010047737A2 (en) 2008-09-02 2010-04-29 Micurx Pharmaceuticals, Inc. Antimicrobial indoline compounds for treatment of bacterial infections
BRPI0919668A2 (pt) 2008-10-21 2018-05-29 Onyx Therapeutics, Inc. terapia de combinação com epóxi-cetonas de peptídeo
CN101798302B (zh) 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
TWI504598B (zh) 2009-03-20 2015-10-21 Onyx Therapeutics Inc 結晶性三肽環氧酮蛋白酶抑制劑
CN101845057B (zh) * 2009-03-27 2013-10-23 四川大学 取代苯酚的甲缩醛磷酸盐麻醉镇静药用化合物及制备方法
GB0905834D0 (en) 2009-04-03 2009-05-20 Seps Pharma Nv Phosphonyl-containing phenolic derivatives useful as medicaments
MY160392A (en) * 2009-05-07 2017-03-15 Univ Minnesota Triptolide prodrugs
US9150600B2 (en) 2009-05-07 2015-10-06 Regents Of The University Of Minnesota Triptolide prodrugs
CN101648973B (zh) * 2009-09-03 2012-05-30 漆又毛 水溶性紫杉烷及制备方法
WO2011060179A1 (en) 2009-11-13 2011-05-19 Onyx Therapeutics, Inc Use of peptide epoxyketones for metastasis suppression
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CN102153607B (zh) * 2010-02-11 2015-07-15 湖南方盛华美医药科技有限公司 水溶性喜树碱衍生物及包含其的药物组合物
EP2542238B1 (en) 2010-03-01 2015-08-12 Onyx Therapeutics, Inc. Compounds for immunoproteasome inhibition
MX2012011355A (es) 2010-03-30 2012-11-30 Phosphagenics Ltd Parche de suministro transdermico.
WO2011136905A2 (en) 2010-04-07 2011-11-03 Onyx Therapeutics, Inc. Crystalline peptide epoxyketone immunoproteasome inhibitor
US8399535B2 (en) * 2010-06-10 2013-03-19 Zimmer, Inc. Polymer [[s]] compositions including an antioxidant
WO2012033952A1 (en) 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. 3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
JP5853028B2 (ja) * 2010-12-02 2016-02-09 カンザス大学 ６−シクロヘキシル−１−ヒドロキシ−４−メチルピリジン−２（１ｈ）−オンのプロドラッグおよびその誘導体
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
ITMI20110580A1 (it) * 2011-04-08 2012-10-09 Chemelectiva S R L Iintermedi utili per la preparazione di fospropofol e processo per la loro preparazione
UY34072A (es) 2011-05-17 2013-01-03 Novartis Ag Derivados sustituidos de indol
CA2849731C (en) 2011-09-22 2020-01-14 Acorda Therapeutics, Inc. Acetaminophen conjugates, compositions and methods of use thereof
CN102516258B (zh) * 2011-11-11 2014-06-25 正大天晴药业集团股份有限公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
CN102382133B (zh) * 2011-12-02 2016-03-23 陕西合成药业股份有限公司 一种磷丙泊酚钠的制备及纯化方法
US9309283B2 (en) 2012-07-09 2016-04-12 Onyx Therapeutics, Inc. Prodrugs of peptide epoxy ketone protease inhibitors
US9580459B2 (en) * 2013-04-26 2017-02-28 Metselex, Inc. Water-soluble ursodeoxycholic acid prodrugs
EP3052562B1 (en) 2013-10-01 2017-11-08 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants
US10981951B2 (en) * 2014-01-31 2021-04-20 Mayo Foundation For Medical Education And Research Therapeutics for the treatment of glaucoma
US9382276B2 (en) 2014-02-21 2016-07-05 Micurx Pharmaceuticals, Inc. Water-soluble O-carbonyl phosphoramidate prodrugs for therapeutic administration
EP3116941A1 (en) 2014-03-12 2017-01-18 Zimmer, Inc. Melt-stabilized ultra high molecular weight polyethylene and method of making the same
JP6567049B2 (ja) 2014-10-21 2019-08-28 アッヴィ・インコーポレイテッド カルビドパおよびｌ−ドーパプロドラッグならびにそれらの使用方法
WO2016090084A1 (en) 2014-12-03 2016-06-09 Zimmer, Inc. Antioxidant-infused ultra high molecular weight polyethylene
CN106674269A (zh) * 2015-11-11 2017-05-17 陕西合成药业股份有限公司 一种磷丙泊酚钠四水合物及晶型及其制备方法和用途
CN106674268A (zh) * 2015-11-11 2017-05-17 陕西合成药业股份有限公司 一种磷丙泊酚钠三水合物及晶型及其制备方法和用途
CN106674270A (zh) * 2015-11-11 2017-05-17 陕西合成药业股份有限公司 一种磷丙泊酚钠无水合物及晶型及其制备方法和用途
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
US10851123B2 (en) * 2016-02-23 2020-12-01 Concentric Analgesics, Inc. Prodrugs of phenolic TRPV1 agonists
EP3445346A1 (en) * 2016-04-20 2019-02-27 AbbVie Inc. Carbidopa and l-dopa prodrugs and methods of use
US11331271B2 (en) * 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
US11929552B2 (en) 2016-07-21 2024-03-12 Astronics Aerosat Corporation Multi-channel communications antenna
NZ754168A (en) 2016-12-21 2024-08-30 Avecho Biotechnology Ltd Process for phosphorylating a complex alcohol
US10992052B2 (en) 2017-08-28 2021-04-27 Astronics Aerosat Corporation Dielectric lens for antenna system
US10174138B1 (en) * 2018-01-25 2019-01-08 University Of Massachusetts Method for forming highly reactive olefin functional polymers
CN109456360B (zh) * 2018-12-17 2021-05-14 河南中医药大学 一种磷丙泊酚钠的制备方法
CN113286796B (zh) * 2019-01-30 2024-07-05 四川科伦博泰生物医药股份有限公司 喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途
US11628178B2 (en) 2019-03-26 2023-04-18 Epalex Corporation Fospropofol methods and compositions
US11478490B1 (en) 2021-03-30 2022-10-25 Epalex Corporation Fospropofol formulations
US11439653B1 (en) 2021-03-30 2022-09-13 Epalex Corporation Fospropofol formulations
US11547714B2 (en) 2020-02-05 2023-01-10 Epalex Corporation Fospropofol salts, methods and compositions
WO2021228150A1 (zh) * 2020-05-13 2021-11-18 成都百裕制药股份有限公司 大麻素衍生物及其制备方法和在医药上的应用
CN117279664A (zh) 2021-04-10 2023-12-22 普方生物制药美国公司 Folr1结合剂、其偶联物及其使用方法
AU2022262644A1 (en) 2021-04-23 2023-11-09 Profoundbio Us Co. Anti-cd70 antibodies, conjugates thereof and methods of using the same
TW202320857A (zh) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2829151A (en) 1952-11-03 1958-04-01 Dow Chemical Co Chlorotoloxy-ethyl phosphates
US3271314A (en) 1958-12-04 1966-09-06 Ethyl Corp 2, 6-diisopropylphenol
GB1146173A (en) 1966-06-18 1969-03-19 Geigy Uk Ltd Production of triaryl phosphates
US3723578A (en) 1970-10-13 1973-03-27 Gaf Corp Phosphate esters of ethers of thiol substituted phenols
US4171272A (en) 1977-12-02 1979-10-16 Fmc Corporation Turbine lubricant
FR2601259B1 (fr) 1986-07-11 1990-06-22 Rhone Poulenc Chimie Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
US4894456A (en) 1987-03-31 1990-01-16 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5053512A (en) 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5122526A (en) 1987-03-31 1992-06-16 Research Triangle Institute Camptothecin and analogs thereof and pharmaceutical compositions and method using them
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5364858A (en) 1987-03-31 1994-11-15 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5244903A (en) 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5106742A (en) 1987-03-31 1992-04-21 Wall Monroe E Camptothecin analogs as potent inhibitors of topoisomerase I
US5180722A (en) 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
US5122606A (en) 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US5049668A (en) 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
MY103951A (en) 1988-01-12 1993-10-30 Kao Corp Detergent composition
CA2014539C (en) 1989-04-17 2000-07-25 Shinichiro Umeda Water borne metallic coating composition
US5091211A (en) 1989-08-17 1992-02-25 Lord Corporation Coating method utilizing phosphoric acid esters
JPH03209414A (ja) 1990-01-12 1991-09-12 Nikon Corp 焦点調節装置
ATE138781T1 (de) 1990-10-17 1996-06-15 Tomen Corp Verfahren und zusammensetzung zur erhöhung der aufnahme und des transportes bioaktiver wirkstoffe in pflanzen
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
MX9308012A (es) 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
CA2129288C (en) 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5646159A (en) 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
IT1270093B (it) 1994-09-28 1997-04-28 Zambon Spa Processo per la purificazione di 2,6-diisopropilfenolo
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US5804682A (en) 1995-11-29 1998-09-08 Henkel Corporation Aqueous dispersions of polyamides
US5637625A (en) 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US5746973A (en) 1996-07-10 1998-05-05 Naraghi; Ali Method for reducing odorant depletion
JP2002501926A (ja) * 1998-01-29 2002-01-22 ブリストル−マイヤーズ スクイブ カンパニー ジアリール１、３、４−オキサジアゾロンのホスフェート誘導体
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols

Also Published As

Publication number Publication date
CN1357000A (zh) 2002-07-03
HUP0200317A3 (en) 2004-07-28
KR20010079627A (ko) 2001-08-22
CY1105043T1 (el) 2010-03-03
HK1047939B (zh) 2005-11-18
US20030176324A1 (en) 2003-09-18
ES2268876T3 (es) 2007-03-16
TR200100772T2 (tr) 2001-12-21
JP4554081B2 (ja) 2010-09-29
US6872838B2 (en) 2005-03-29
HU229401B1 (en) 2013-12-30
US6451776B2 (en) 2002-09-17
US20050090431A1 (en) 2005-04-28
NO20010659L (no) 2001-04-06
EP1683803A1 (en) 2006-07-26
IL141316A0 (en) 2002-03-10
CA2339834C (en) 2011-01-25
HUP0200317A2 (en) 2002-06-29
PT1102776E (pt) 2007-02-28
EP1102776A1 (en) 2001-05-30
US6204257B1 (en) 2001-03-20
ZA200101039B (en) 2002-02-05
PL347211A1 (en) 2002-03-25
RU2235727C2 (ru) 2004-09-10
MXPA01001431A (es) 2002-11-29
NO330357B1 (no) 2011-04-04
CN1198834C (zh) 2005-04-27
AU5339499A (en) 2000-02-28
NO20010659D0 (no) 2001-02-07
US20010025035A1 (en) 2001-09-27
PL198141B1 (pl) 2008-05-30
NZ509795A (en) 2003-10-31
DE69930269D1 (de) 2006-05-04
KR100662799B1 (ko) 2007-01-02
JP2002522443A (ja) 2002-07-23
AU769755B2 (en) 2004-02-05
CA2339834A1 (en) 2000-02-17
UA73479C2 (uk) 2005-08-15
CZ304020B6 (cs) 2013-08-28
CN1680402A (zh) 2005-10-12
HK1047939A1 (en) 2003-03-14
IL141316A (en) 2004-06-20
EP1102776B1 (en) 2006-03-08
CZ2001479A3 (cs) 2001-09-12
WO2000008033A1 (en) 2000-02-17
US7244718B2 (en) 2007-07-17
ATE319723T1 (de) 2006-03-15
DE69930269T2 (de) 2006-12-07
BR9912853A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
DK1102776T3 (da) Vandoplöselige prodrugs af hindrede phenoler
IL143747A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
BR9900788A (pt) Compostos ésteres.
BR9205854A (pt) Composiçoes de mistura curavel por UV e processos.
PT1189970E (pt) Aditivo carboxi-funcional para a condensacao de poliamidas
BR9912392A (pt) Benzoilcicloexanodionas substituìdas
CA2136509A1 (en) Benzophenone Derivative, and Ultraviolet Light Absorbent and an Endermic Liniment
DK0429627T3 (da) Derivater af quinolin-3-carboxanilider
BR0111780A (pt) Agente herbicida
GT199900011A (es) Nuevos derivados del acido dihidroxihexanoico
DE69926379D1 (de) Verfahren zur herstellung von 2-(2,4-dihydroxyphenyl) or 2-(2,4-dialkoxyphenyl) -4,6-bisaryl-1,3,5-triazine
DK0785949T3 (da) Fremgangsmåde til oprensning af keratinocytvækstfaktorer
ATE277026T1 (de) Naphthylverbindungen, zusammensetzungen und verfahren
ES2154692T3 (es) Dihidrofarnesal.
UY24596A1 (es) Nuevos derivados sintéticos del catecol
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
DK1151130T3 (da) Coenzym, der er nyttigt til syntese af L-carnitin
DK0908184T3 (da) Præparat på basis af fortyndet havvand beregnet til vaskning af nasale fossae
DE69724548D1 (de) Substituierte 2,3-Aryl-Benzothiophene und ihre östrogene Aktivität
HN1999000027A (es) Nuevas composiciones herbicidas
ES2053424T1 (es) Humiatos modificados, procedimiento para su preparacion y utilizacion.
BR9907697A (pt) Carbonatos de serina
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
EP0495450A3 (en) Polyamine phenols as radioprotective agents